Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions
NCT00778037
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Cyclobenzaprine hydrochloride 10 mg tablet
Sponsor
Ranbaxy Laboratories Limited